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Abstract
Background: The recent discovery that methylated cytosines are converted to 5-hydroxymethylated cytosines (5hmC)
by the family of ten-eleven translocation enzymes has sparked significant interest on the genomic location, the
abundance in different tissues, the putative functions, and the stability of this epigenetic mark. 5hmC plays a key
role in the brain, where it is particularly abundant and dynamic during development.
Results: Here, we comprehensively characterize 5hmC in the prefrontal cortices of 24 subjects. We show that,
although there is inter-individual variability in 5hmC content among unrelated individuals, approximately 8 %
of all CpGs on autosomal chromosomes contain 5hmC, while sex chromosomes contain far less. Our data also provide
evidence suggesting that 5hmC has transcriptional regulatory properties, as the density of 5hmC was highest
in enhancer regions and within exons. Furthermore, we link increased 5hmC density to histone modification
binding sites, to the gene bodies of actively transcribed genes, and to exon-intron boundaries. Finally, we
provide several genomic regions of interest that contain gender-specific 5hmC.
Conclusions: Collectively, these results present an important reference for the growing number of studies
that are interested in the investigation of the role of 5hmC in brain and mental disorders.
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Background
In mammalian cells, 5-methylcytosine (5mC) has been the
most widely studied epigenetic mark, and has long been
regarded as a stable DNA modification. Recently, however,
research has shown that 5mC can be oxidized to 5-
hydroxymethylcytosine (5hmC) by the ten-eleven trans-
location (TET) family of proteins [1–3]. 5hmC has been
shown to be most abundant in brain tissue [4–6] and to
influence transcriptional regulatory activity [7–10].
Although its role is not yet completely understood,
5hmC has been increasingly investigated in neuropsy-
chiatric phenotypes, likely due to its involvement in
neuronal development and enrichment in brain tissue
[11, 12]. In humans, global levels of 5hmC have been
shown to be reduced in Alzheimer’s disease [13], while
site-specific differences have been demonstrated in
autism spectrum disorder [14], Huntington’s disease
[15], and psychosis [16]. In mouse models, genome-wide
alterations have also been observed in Huntington’s dis-
ease [17], as well as in fragile X-associated tremor/ataxia
syndrome [18]. Taken together, these observations sug-
gest a significant role of 5hmC in the etiology of neuro-
psychiatric diseases.
To date, however, investigations of 5hmC in the hu-
man brain have either been in very small samples or
have utilized low-throughput techniques. Here, we use a
sample with good power and sequencing resolution to
provide insight into genomic characteristics of 5hmC in
the brain. Although we observe sizable variability of
5hmC between subjects, lending to the hypothesis of a
dynamic cytosine-modifying pathway, we also demon-
strate a strong association between stable 5hmC and epi-
genetic properties. In its entirety, the descriptive data
presented here provide a map of 5hmC at single base
resolution, which is of interest to future studies of 5hmC
in the cortex of the human brain.
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Several high-throughput epigenetic sequencing protocols
rely on restriction enzymes, such as MspI and HpaII. In
this study, we used AbaSI, an enzyme that recognized
glucosyl-modified cytosines and created a cut site 11–13
base pairs downstream of this modified cytosine [19],
followed by sequencing to conduct a whole-genome
5hmC analysis at single-base resolution. We initially
studied DNA from prefrontal cortical samples from 19
male subjects. As expected, our sequencing results con-
sistently showed that 40–45 % of all reads contained
cytosine and guanine bases, respectively, at the 11th and
12th positions after the adaptor sequence (Fig. 1a). This
confirmed the specificity of the enzyme, as 5hmC occurs
almost exclusively in CpG sequences in both fetal and
adult mammalian brain [8, 9]. This value was also ex-
pected since, methodologically, half of the sequenced
reads were not expected to contain a CpG dinucleotide
at these positions and, therefore, were discarded during
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Fig. 1 Quality metrics show the efficacy of the AbaSI enzyme, sufficient depth of sequencing, and suitability of sample. a The AbaSI enzyme is
said to cut 11-13 bp downstream of a glucosylated 5hmC. An example from a sequencing quality control plot showed a peak of cytosine and
guanine bases at the 11th and 12th positions of sequencing reads, respectively. b No correlation was observed between the number of uniquely
mapped AbaSI-Seq reads and the number of 5hmC detected per subject, thereby showing sufficient depth of sequencing. c-d No correlation was
observed between either the subjects’ ages (c) or their PMIs (d) and the total number of 5hmC sites detected
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bioinformatic analyses. We generated an average of
109,394,675 single end reads per subject, of which an aver-
age of 82,210,131 ± 4,498,459 reads passed multiple filter-
ing steps and were used to generate the data presented
here (Additional file 1). We plotted the number of aligned
reads against the number of unique 5hmC sites detected
and found that 60–80 million reads was an optimal range;
there were four subjects with >90 million uniquely aligned
reads and the number of 5hmC sites in these subjects was
not notably different from most subjects with 60–80 mil-
lion reads (Fig. 1b). This sugested diminishing returns of
5hmC detectabiliy under these experimental parameters
after ~60–80 million reads. We next assessed the effects
of age and post-mortem delay, two factors that might
affect 5hmC leves, and found no signficant correlation
(Fig. 1c, d).
Genome-wide inter-individual differences of 5hmC
A major focus of this study was to determine whether
5hmC sites were present at similar genomic locations in
brain tissue from different individuals. We first investi-
gated what proportion of all 5hmC sites were common to
multiple individuals. We identified a total of 17,368,538
unique 5hmC sites across 19 individuals, of which 81.3 %
were also identified in a previous study examining 5hmC
content in the prefrontal cortex using Tet-assisted bisulfite
sequencing (TAB-Seq) [9]. We found that 41.7 % of all
5hmC sites observed were found in at least 5 individuals,
whereas 12.2 % of all 5hmC sites were common to at least
10 individuals, and only 1.3 % were common to at least 15
individuals (Additional file 2). As a point of comparison,
we investigated the proportion of 5mC sites common to
multiple individuals by whole genome bisulfite sequencing
(WGBS). 5mC showed considerable stability across the 19
subjects investigated when considering 5, 10, or 15 indi-
viduals, however we observed an abrupt decrease in the
percentage of sites common to all 19 subjects (Additional
file 3). Although these data indicated that 5hmC is consid-
erably more variable than 5mC, they also suggested a rela-
tive degree of stability of 5hmC sites in brain tissue from
different individuals.
We next assessed the probability of detecting similar
5hmC sites between any two individuals. To do so, we se-
lected two representative samples with respect to sequen-
cing depth and number of unique 5hmC sites. We
subsequently calculated the hypergeometric probability of
detecting the same 5hmCs in sequencing reads across in-
dependent samples. First, we estimated the total number
of 5hmC sites in the human brain genome to be around
27 million, based on previously published data [9]. We ob-
served 6,793,582 and 3,818,749 total 5hmC sites in each
of the representative samples considered in this ana-
lysis, of which 1,999,493 5hmC sites were common to
both subjects (P < 3.34e−178), suggesting that the pattern
of common 5hmC sites observed between samples was
not random.
Chromsomal distribution of 5hmC in human prefrontal
cortex
While we observed a strong overlap of 5hmC across indi-
viduals, we opted to perform the following analyses ac-
cording to three levels of stringency; low, intermediate,
and high stringencies, which represented all 5hmC sites
common to ~25, 50, and 75 % of the total sample, respect-
ively. In the low stringency group, an average of 25.7 ± 1.1
% of all autosomal CGs contained a hydroxymethyl mark,
while 7.4 ± 2.3 % and 0.8 ± 0.4 % of CGs contained a hy-
droxymethyl mark in the intermediate and high stringency
groups, respectively (Fig. 2a–f, Additional file 4).
The total number of 5hmC sites analyzed in the inter-
mediate stringency model was 2,121,951, which was
slightly lower than the average number of 5hmC sites
observed in any single individual (4,277,308 ± 319,846).
Furthermore, 94.75 % of sites in the intermediate strin-
gency were also present in a recent TAB-Seq study of
the prefrontal cortex of one individual human female
[9]. For these reasons, we focused further analyses on
the intermediate stringency model.
5hmC densities across chromosomal features
We next determined the density of 5hmC on each
chromsome and within specific chromosomal features.
We defined the density as being the total number of
5hmC sites corrected for the total number of CGs on
the chromosome and the chromosome length. We ob-
served the density of 5hmC to be quite stable across
autosomal chromosomes, although a relative increase in
density was observed in chromosomes 18, 20, 21, and 22
compared to other chromosomes. Interestingly, in com-
parison to the autosomes, the density of 5hmC was
greatly decreased in the sex chromosomes and increased
in mitochondrial DNA (Fig. 3a).
The density of 5hmC across chromosomal features is
of interest as it may provide insight into its potential
functional properties. Genomic features were defined
based on GRCh37/hg19 genomic annotations down-
loaded from the UCSC browser and Ensembl release 75.
Our data showed an increase in 5hmC density in both
poised and active enhancers, as well as in exons (Fig. 3b).
The increase in 5hmC in these regions has been previ-
ously observed in human embryonic stem cells [20, 21]
and both fetal and adult mouse brain [8]. In contrast,
5hmC density appeared to be relatively depleted in tran-
scription start sites (TSS), CpG shores, and, most strik-
ingly, CpG islands and both long and short interspersed
elements (LINEs and SINEs, respectively).
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Potential functional properties of 5hmC
The observed increase in 5hmC density in enhancer
regions of the genome led to the hypothesis that 5hmC
may also be associated with histone marks on an individ-
ual basis. Using data from chromatin maps in the frontal
lobe [22], we calculated the mean 5hmC levels in contigu-
ous 100 bp bins flanking the proposed histone modifica-
tion binding site. Consistent with the results showing
increased density of 5hmC in poised enhancer regions
(Fig. 3b), we also observed an increase in 5hmC density at
the H3K4me1 ChIP-Seq peak (Fig. 3c). In addition, oppos-
ite results were seen at both the H3K4me3 and H3K27ac
ChIP-Seq peaks, as the density of 5hmC decreased at the
midpoint for both histone marks (Fig. 3c).
Similar to histone and cytosine methylation, 5hmC may
be an epigenetic mark that associates with altered gene
transcription. To explore this possibility further, we com-
pared 5hmC densities across the gene body to available
RNA-Seq data from the prefrontal cortex of 11 independ-
ent control samples [23]. We plotted 5hmC density along
the gene body for all genes separated in quartiles by their
expression levels. We found that 5hmC was enriched in
the gene bodies of highly expressed genes (Fig. 4a). This
was consistent with similar associations between gene
body 5hmC and actively transcribed genes reported previ-
ously in limited human and mouse brain samples [8, 9], as
well as mouse neuronal cells [7]. In addition to gene body
5hmC, genes with the highest expression also showed the
greatest reduction in 5hmC at the TSS (Fig. 4a), even
though the TSS of highly expressed genes had an overall
increase in CpG density compared to the TSS of lowly
expressed genes.
Along with the putative function of 5hmC in regulating
gene transcription, two previous reports have also sug-
gested an association between 5hmC and exon-intron
boundaries [9, 24]. We looked at 5hmC content across
20 bp flanking the 5’ and 3’ ends of 144,157 internal exons
spanning 20,745 genes. We observed patterns of increased
5hmC at exon-intron boundaries, specifically at the 5’
splice site and four bases downstream (Fig. 4b). This spike
in 5hmC was not strand-specific, as similar results were
obtained on both the sense and anti-sense strands (Fig. 4c).
The present results may be indicative of a potential
splicing mechanism, perhaps through the association of
5hmC and the CCCTC-binding factor (CTCF). Not only



































































































































































































































































































































































Fig. 2 The total number of hydroxymethylated CGs per chromosome decreased exponentially with increasing stringency. Plots displaying the total
number of 5hmC sites for each chromosome corrected for the total number of CGs on the respective chromosome, for low (a), intermediate (b), and
high (c) stringencies. Summary plots for autosomes, sex chromosomes, and mitochondrial DNA are shown for each respective stringency (d-f)
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alternative splicing by regulating the activity of RNA poly-
merase II [25], but it has also been shown to interact with
5hmC and TET enzymes in both mouse and human
embryonic stem cells [21, 26, 27]. Taken together, these
results provide an interesting avenue for further research
into alternative splicing mechanisms.
Brain 5hmC clusters are predominant in genes associated
with neurodevelopment
Given the association of 5hmC with regulatory processes,
we next wanted to determine whether 5hmC aggregated
in specific genes. We defined a cluster as being a region
containing at least three 5hmCs, each within 200 bp of
each other. Using the 2,121,951 5hmC sites in the inter-
mediate stringency category, we identified a total of
65,898 clusters. The midpoint of each cluster was then as-
sociated to the TSS of the nearest gene. A total of 8,713
genes were analyzed using GeneTrail [28] for gene
ontology (GO). A variety of terms related to cellular, meta-
bolic, and signaling processes were significantly associated
with 5hmC clusters. Furthermore, of particular interest,
we observed an enrichment of terms associated with
neurological processes and neurodevelopment, including
terms related to nervous system development, neurogen-
esis, and gliogenesis (Table 1). Additional significant terms
included those related to other areas of development and
epigenetic processes. The complete list of GO terms can
be found in Additional file 5.
Sex differences in 5hmC in the human prefrontal cortex
In males, the density of 5hmC on the sex chromosomes
(mean = 4.43e−11 ± 2.37e−12) was nearly 10-fold lower
(two-tailed P < 0.0001) compared to the autosomes
(mean = 6.08e−10 ± 3.56e−11) (Fig. 3a), suggesting differ-
ential 5hmC patterns between chromosome types. To




Fig. 3 5hmC densities on chromosomes, within genomic features, and around histone modification binding sites. a 5hmC density remained relatively
stable from one chromosome to the next, although the density appeared to show more variability on shorter chromosomes. 5hmC density was also
far greater on autosomal chromosomes than the two sex chromosomes (two-tailed P < 0.0001). b 5hmC was most highly abundant in enhancer
elements and gene bodies, while its density decreased in CpG islands, the TSS, and repetitive elements. c Increased 5hmC was observed at the
H3K4me1 binding site, while the opposite was true for both H3K4me3 and H3K27ac binding sites
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AbaSI-Seq analysis using DNA from the prefrontal cor-
tex from females (n = 5). Similar to our experiment in
males, we used all sites common to a proportion of sub-
jects (at least 3 individuals), which is equivalent to the
intermediate stringency model, to plot the density of
5hmC across all chromosomes. As in the analysis with
males only, the density of 5hmC was increased on chro-
mosomes 18, 20, 21, and 22, while remaining quite
stable across all other autosomes (Fig. 5a). Interestingly,
the difference in 5hmC density between males and fe-
males became larger as the chromosome size decreased
(Fig. 5b).
To identify differences in 5hmC patterns between males
and females, we reasoned that differential clusters of
5hmC on any chromosome might indicate potential regu-
latory regions. As such, to identify 5hmC clusters unique
to males, we sampled five randomly selected sets of 5
males and compared 5hmC sites in each set to those
found in the females. We identified 27,410 5hmC clusters,
associated with 7,064 genes, which were both unique to
males and common in all five randomly selected sets. Sub-
sequent GO analysis identified an enrichment in genes re-
lated to anatomical and system development, among
others (Additional file 6). To determine female-specific
5hmC clusters, we compared all 5hmC sites on autosomes
and the sex chromosomes, found in both the female
(11,054,815 sites) and male samples (17,368,538 5hmC
sites). In doing so, we identified 707,549 5hmC sites
unique to the females included in this study, which might
represent gender-specific 5hmC sites. A cluster analysis of
these 5hmC sites specific to females indicated a total of
12,034 clusters, which were associated to 4,417 genes. GO
analysis identified terms related to organ morphogenesis,
anatomical structure development, and system develop-
ment, among others (Table 2, Additional file 7). Of par-
ticular interest were 2 clusters on the anti-Müllerian
Hormone (AMH) gene, one of which contained three





















































Fig. 4 5hmC was enriched in the gene bodies of highly expressed genes and at exon-intron boundaries. a 5hmC density was plotted against
genomic location for all genes separated in quartiles by their expression levels. 5hmC showed the greatest decrease in density at the TSS for
highly expressed genes, while also showing the greatest increase in density in the gene body for this same group. The opposite trend was seen
in genes in the lowest quartile of expression. An interesting spike in 5hmC density was also observed at the TES in all quartiles of expression. b 5hmC
density is increased in the exons on the 5’ and 3’ ends of exon-intron boundaries. c A similar pattern of 5hmC density was also seen on the anti-sense
strand of corresponding exon-intron boundaries. (TSS = transcription start site; TES = transcription end site)
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exon 3 and the other containing seven 5hmC sites
within a 557 bp region of the 3’ untranslated region
(UTR) (Fig. 6a). According to the RNA-Seq data, AMH
was expressed in the frontal cortex. We observed
increased 5hmC density in the gene body and a spike in
5hmC density at the transcription end site (TES), both
of which were in agreement with the two clusters found
in the AMH gene. AMH is associated with gender-
Table 1 GO terms related to neurological, epigenetic, and developmental processes from cluster analysis in intermediate stringency
Neurological Expected Observed p-value (fdr) Enrichment
Neurological system process 616.197 485 2.86E-13 down
Neurogenesis 332.402 396 7.11E-06 up
Neuron projection 190.242 237 1.74E-05 up
Generation of neurons 309.405 366 4.80E-05 up
Neuron differentiation 281.183 333 0.000109238 up
Axon 91.4627 117 0.00142957 up
Cell morphogenesis involved in neuron differentiation 124.389 151 0.00563766 up
Neuron projection morphogenesis 127.525 154 0.00684608 up
Glial cell differentiation 39.721 53 0.0202685 up
Regulation of neuron differentiation 93.0307 113 0.0215321 up
Gliogenesis 46.5153 60 0.0317942 up
Regulation of neurogenesis 113.414 134 0.0340942 up
Epigenetic Expected Observed p-value (fdr) Enrichment
Protein amino acid methylation 25.0869 35 0.0332904 up
Lysine N-methyltransferase activity 18.8152 27 0.0455873 up
Protein-lysine N-methyltransferase activity 18.8152 27 0.0455873 up
Histone-lysine N-methyltransferase activity 18.8152 27 0.0455873 up
N-methyltransferase activity 29.7907 40 0.0461752 up
Histone H2A acetylation 6.27173 11 0.0496797 up
Development Expected Observed p-value (fdr) Enrichment
Sensory perception of smell 189.197 33 1.42E-66 down
Sensory perception of chemical stimulus 209.58 50 3.33E-61 down
Sensory perception 389.37 253 6.42E-22 down
Developmental process 1748.24 1912 1.16E-08 up
System development 1318.63 1463 2.08E-08 up
Anatomical structure development 1460.79 1608 4.39E-08 up
Multicellular organismal development 1593.54 1744 6.81E-08 up
Nervous system development 603.131 699 1.78E-07 up
Regulation of developmental process 413.934 494 1.94E-07 up
Positive regulation of developmental process 182.925 236 3.04E-07 up
Neuron development 205.399 249 0.000157004 up
Forebrain development 90.4174 118 0.000419088 up
Central nervous system development 239.371 282 0.000802517 up
Neuron projection development 166.723 200 0.00211809 up
Sensory organ development 129.093 154 0.0128753 up
Regulation of nervous system development 123.344 146 0.0233886 up
Brain development 163.588 189 0.0279154 up
Post-embryonic development 33.4492 45 0.0307565 up
Regulation of neuron projection development 56.4456 71 0.0355767 up
Embryonic development 321.949 354 0.0476929 up
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specific development as it is expressed in males up to
puberty to suppress the development of the fallopian
tubes and ovaries [29]. In females, however, AMH is
most highly expressed between puberty and meno-
pause, as it recruits primary follicles in the ovaries
[29]. Given the hypothesis that 5hmC is associated
with active transcription, one would expect few to no
5hmC clusters in the AMH gene in males. Indeed,
none of the 65,898 clusters found in the male cluster
analysis, using all sites common in at least 10 males,
were in the AMH gene.
Using the publicly available RNA-Seq data [23], we in-
vestigated genes showing differential expression between
genders (Additional file 8). This data showed the X-
linked zinc finger protein (ZFX) gene on the X chromo-
some to be one of the most significantly differentially
expressed genes in females (log2 FC = 0.653; FDR-
corrected P < 0.0001). Of the 5hmC clusters unique to fe-
males, two are located within the ZFX intergenic region
(Fig. 6b). ZFX, which has been shown to escape X-
inactivation, is analogous to the Y-linked zinc finger pro-
tein (ZFY) on the Y chromosome, and both have been
a) 
b) 
Fig. 5 5hmC density in females showed similar patterns as those in males. a Similar to males, 5hmC density remained stable across chromosomes,
with slight increases observed on chromosomes 18, 20, 21, and 22. b 5hmC density between males and females showed similar trends from one
chromosome to the next, although gender differences in 5hmC density became more pronounced as the chromosome size decreased
Table 2 GO terms related to sexual differentiation and development in 5hmC clusters unique to females
GO term Expected Observed p-value (fdr) Enrichment
Organ morphogenesis 172.483 249 2.94E-09 up
Anatomical structure morphogenesis 362.983 462 5.47E-08 up
Anatomical structure development 740.538 864 5.41E-07 up
System development 668.472 785 8.92E-07 up
Organ development 502.877 603 2.39E-06 up
Tissue development 215.405 269 0.000475655 up
Anatomical structure formation involved in morphogenesis 121.878 161 0.0010206 up
Regulation of anatomical structure morphogenesis 81.6049 109 0.00786336 up




Fig. 6 Cluster analysis of 5hmC sites unique to females showed clusters related to gender differentiation. a Two 5hmC clusters unique to females
were found in the gene body and 3’ UTR of the AMH gene. Both were present within a CpG island, with one also being present around a miRNA
binding site. b 5hmC clusters unique to females were also present in the ZFX gene that was differentially expressed in females compared to males
(log2 FC = 0.6533; FDR p < 0.0001). c Analysis of 5hmC density in females also revealed a significant increase in intergenic 5hmC in genes escaping
X-inactivation. Genes most likely to escape (Escaped9) showed a marginal increase in intergenic 5hmC compared to other levels of potential to escape
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linked to sex determination [30–33]. Similar to AMH,
none of the clusters, using all sites common in at least 10
males, were found in the ZFX gene.
Genes escaping X-inactivation show greater gene body
5hmC density
Following the results showing gender-specific differentially
hydroxymethylated regions (DhmRs) in genes related to
sexual anatomical development, we hypothesized that
5hmC may play a role in additional gender related devel-
opmental processes. 5mC plays an important role in X-
inactivation, and previous literature showed that genes
escaping X-inactivation have a decrease in promoter CG
methylation and an increase in intragenic CH methylation
[8]. Previous studies have separated genes on a scale from
1 to 9, with 1 and 9 respectively indicating genes least or
most likely to escape inactivation. Using all sites found in
our female subjects, our results indicated that these same
genes that escape X-inactivation also show a significant in-
crease in gene body 5hmC compared to genes that remain
inactivated (Fig. 6c). Furthermore, genes that are most
likely to escape X-inactivation showed even greater inter-
genic 5hmC density. Although this is only an initial
characterization, it provides an interesting avenue for fu-
ture studies investigating the potential etiology of X-linked
diseases or disorders.
Discussion and conclusions
In this study, we provide a deep characterization of the
genomic locations of 5hmC in the human prefrontal cor-
tex in a large sample. Using AbaSI-Seq, a high-throughput
technique, we confirm previously published work using ei-
ther low-throughput techniques or single samples. Fur-
thermore, we extend the current knowledge of the role of
5hmC in the brain by linking stable 5hmC sites to enhan-
cer regions and exon-intron junctions, both of which are
involved in gene transcription. We also show the existence
of regions of the genome that contain gender-specific
5hmC patterns, in addition to providing a putative mech-
anism for how certain genes escape X-inactivation. These
data are of interest, as genomic mapping of 5hmC in the
prefrontal cortex will likely be of reference for future stud-
ies investigating brain and mental disorders.
Inter-individual variability is common across many
fields of study. This is especially true in epigenetics,
where both the environment and the genetic landscape
are contributing factors in establishing epigenetic fea-
tures [34–37]. It is, therefore, not surprising to see
varying degrees of 5hmC across the chromosomes and
specific genomic features. These findings provide a
basis for a dynamic DNA demethylation pathway. More
importantly, our data show regions of the genome that
are consistently hydroxymethylated in many individ-
uals. These results confirm the stability of 5hmC in the
human genome and provide a foundation for furthering
our understanding of the epigenetic properties of
5hmC. Similarly, we show that, in order to increase our
understanding of 5hmC, future research will have to be
performed on large samples. Furthermore, increased
stringency of bioinformatics analyses will reduce levels
of random variability, thereby enhancing the power of
studies to infer biological relevance from the 5hmC
sequencing data.
In this study, we show that an intermediate level of
stringency, defined as 5hmC sites present in at least
half the total sample, was appropriate in discovering re-
gions with a consistently high density of 5hmC across
subjects. Our results provide reliable evidence that
5hmC is associated with gene regulatory features, such
as enhancer regions and histone marks that associate
with active gene transcription. Furthermore, we add to
the available data in mammalian cells and tissues show-
ing a clear correlation between gene body 5hmC and
highly expressed genes. Finally, our cluster analyses
show an increased density of 5hmC in genes associated
with many developmental processes, specifically those
related to neurogenesis and nervous system develop-
ment. These results are of interest considering the
many publications that have linked 5hmC to neurode-
velopment, neurodegenerative, and neuropsychiatric
phenotypes, and are consistent with the role of 5hmC
and 5mC in tissue-specific gene regulation [7, 38], thus
supporting the internal validity of our findings. Al-
though the exact function of 5hmC remains unknown,
our findings lend to the idea that 5hmC may act as an
epigenetic mark by regulating gene transcription.
In addition to characterizing 5hmC in a large sample,
we also provide evidence to suggest that 5hmC may be
an important factor in anatomical development. Not
only do GO analyses of unique DhmRs in females show
clusters of 5hmC on genes associated with gender-
specific properties and functions, but our results also
indicate that genes escaping X-inactivation have in-
creased intragenic 5hmC density. Early research into
5hmC and TET proteins showed specific properties of
each based on developmental stages. For example,
TET1 and TET2 are more highly expressed in primor-
dial germ cells, while TET3 is primary found in zygotes
[39, 40]. Similarly, levels of 5hmC tend to be high in zy-
gotes, decrease rapidly during cell division, and are
reestablished in the blastocyst [41]. Interestingly, TET
protein knockdown and knockout experiments show
that TET proteins appear to have redundant and compen-
satory roles in establishing 5hmC patterns [40, 42, 43]. As
such, although the exact function of 5hmC in develop-
ment remains unclear, the presence of gender-specific
DhmRs highlights the putative roles of 5hmC and TET
proteins in embryonic and adult development.
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Whether 5hmC is solely an intermediate molecule in
the process of DNA demethylation or whether this 6th
DNA base may have additional regulatory properties is a
question that remains at the forefront of 5hmC research.
Recent literature has shown that the oxidation of 5mC
to 5hmC occurs on the parental strand after replication,
and in the presence of a stable pool of 5hmC in multiple
tissues from adult mice [44]. Furthermore, several stud-
ies have shown the existence of 5hmC in RNA, from ar-
chaeal species to mammalian cells, that occurs through
the TET-mediated oxidation of 5mC [45, 46]. Certainly,
although 5hmC marks may continue through the
oxidation pathway and ultimately lead to a demethy-
lated cytosine, mounting evidence, including those pre-
sented here, all suggest that 5hmC does regulate gene
transcription. Its mechanism of action, however, re-
mains to be elucidated.
In addition to providing characterizations of 5hmC
genomic location and function, we also confirm the effi-
cacy of a high-throughput method to appropriately de-
tect 5hmC sites at single base resolution. AbaSI-Seq,
which has been used previously in embryonic stem cells,
bases itself on a 5hmC-sensitive restriction enzyme di-
gestion. This technique is valuable as it avoids the biases
caused by antibody-based approaches [47] and does not
cause DNA damage like other methods that employ bi-
sulfite conversion [48]. Furthermore, AbaSI has inde-
pendently been shown to recognize both glucosylated
and non-glucosylated 5hmC [49], thereby increasing its
validity as an effective tool in studying 5hmC.
In summary, this manuscript provides a comprehen-
sive assessment of 5hmC in human prefrontal cortex
using a high-throughput technique. Moreover, we pro-
vide a reference for comparison of 5hmC in other mam-
malian species, and shed light on potential avenues of
interest for further research in determining the func-
tional relevance of 5hmC.
Methods
Subjects
Post-mortem human brain tissue from the prefrontal
cortex was obtained from the Douglas – Bell Canada
Brain Bank. The prefrontal cortex was chosen given its
diverse functions relative to human cognition and of im-
portance to neuropsychiatric phenotypes. Additionally,
the prefrontal cortex has been widely implicated in a
variety of mental illnesses through dysregulation of epi-
genetic mechanisms [50–56]. Brain tissue used in this
study was dissected at 4 °C, snap-frozen in liquid nitro-
gen, and stored at −80 °C following standard procedures.
The Quebec Coroner’s office assessed the cause of death
for each subject, and subsequently, we obtained informa-
tion on the subjects’ mental health using psychological
autopsies using the Structured Clinical Interviews for
DSM-IV Axis 1 [57]. In addition, brain tissue samples
from all subjects were assessed for absence of pathological
processes by a neuropathologist. Subjects died from either
natural (n = 11) or accidental (n = 13) causes, and all were
psychiatrically and neurologically healthy. All subjects
were French-Canadian. Mean age was 43.33 ± 4.46 years.
Written informed consent was obtained from next-of-kin
for all subjects, and the Douglas Institute Research Ethics
Board approved this study.
AbaSI-Seq
Genomic DNA was extracted from the prefrontal cortex
using QIAGEN’s QIAamp DNA Mini Kit (QIAGEN, cat.
# 51304). Concentrations of genomic DNA were assessed
using the Thermo Scientific Nanodrop 1000 spectropho-
tometer and each sample had a 260/280 ratio greater than
1.8. AbaSI-Seq library construction was performed as
described previously [19]. Briefly, DNA was glucosylated
by using UDP-glucose and T4-β-glucosyltransferase (New
England Biolabs, cat. #M0357L). The DNA was then
digested using AbaSI (New England Biolabs, cat. #R0665S)
and custom biotinylated adaptors were ligated to DNA
ends. The DNA was then sheared using the Covaris S220
Focused-Ultrasonicator (peak incident power = 140; duty
% = 10; cycles per burst = 200; time = 120 s). Sheared DNA
was captured using Dynabeads® MyOne™ Streptavidin C1
beads (Life Technologies, cat. # 65001). NEBNext™ End
Repair Module (New England Biolabs, cat. #E6050L) and
NEBNext™ dA-Tailing Module (New England Biolabs, cat.
#E6053L) were used to generate blunt ended fragments
and create an adenosine tail, respectively. A second set of
custom adaptors were ligated to the DNA, followed by
PCR amplification using NEBNext™ High-Fidelity 2x PCR
Master Mix (New England Biolabs, cat. #E6013AA). Illu-
mina TruSeq indices 1 through 12 were used to barcode
samples. 50 cycle, single-read sequencing was performed
on Illumina’s HiSeq 2000. A minimum of 60,000,000
sequencing reads was obtained per subject. Sequencing
quality control metrics can be found in Additional file 1.
Data processing
FASTQ reads were filtered based on a quality score
greater than 30 and were then aligned to the human refer-
ence genome (UCSC Hg19) using Bowtie 2 (http://bowtie-
bio.sourceforge.net/bowtie2/index.shtml), with the preset
parameters of very-sensitive (−D 20 -R 3 -N 0 -L 20 -i
S,1,0.50). Duplicates were removed using Picard (http://
broadinstitute.github.io/picard/) and realignment was
performed using the GATK alignment procedures from
the Broad Institute (https://www.broadinstitute.org/gatk/).
Subsequent filtering of aligned reads was based on a
quality score of greater or equal to 10. 5hmC sites were
identified using a custom PERL script [19] that detected
potential 5hmC sites based on their expected distance
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from the AbaSI enzymatic cleavage site. A combination
of BEDtools, R packages, and custom scripts were used




All 5hmC sites in the intermediate stringency were used
to assess chromosomal 5hmC density. Density was de-
fined as the total number of 5hmC sites per chromo-
some, corrected for the length of the chromosome and
the total number of CGs on the chromosome.
Genetic features
5hmC sites in the intermediate stringency category were
plotted against genomic regions and corrected for the
length of the region and the number of CGs within the
region. All genomic features were defined based on the
GRCh37/hg19 genomic annotation downloaded from
the UCSC database. Different genic elements, including
transcription start sites (TSS), exons, introns, and tran-
scription end sites (TES), were defined based on the
Ensembl (release 75). Since genes can have multiple
transcripts, we selected the 5’-most TSS on the positive
strand as the single TSS associated with each gene. The
reverse (3’ most TSS) was done for genes on the nega-
tive strand. We limited downstream analysis to protein-
coding genes, resulting in 20,745 TSSs in total. Similarly,
annotations for retro-elements (i.e., LINEs and SINEs)
and CpG islands were acquired from the UCSC data-
base. CpG shores were defined as the 2 kb flanking a
CpG island. Coordinates of predicted of promoter and
enhancer regions were obtained from recently published
genome-wide maps of chromatin states in the adult
brain midfrontal lobe [22], including H3K4me3,
H3K4me1 and H3K27ac. Two types of enhancers were
distinguished: active enhancers that were simultaneously
marked by distal H3K4me1 and H3K27ac, and poised
enhancers that were solely marked by distal H3K4me1
[9, 58].
ChIP-Seq peaks
To plot 5hmC profiles around ChIP-Seq peaks, the mean
5hmC was calculated for each contiguous 100 bp bin
from 3 kb upstream to 3 kb downstream of the central
position of the peak.
RNA-Seq
Gene expression counts were obtained from RNA-seq
data from the preferontal cortex of 11 controls subjects
from previously published work [23]. Genes were then
classified into quartiles based on their basal gene expres-
sion levels: 1st quartile is lowest and 4th is highest. Gene
bodies and 20 kb regions upstream and downstream
were each divided into 50 intervals. We gathered hydro-
xymethylation data from windows within each of these
intervals and plotted the mean hydroxymethylation level
for all windows overlapping each position.
Exon-intron boundaries
A total of 144,157 internal exons representing 20,745
genes were retrieved from the Ensembl database, with ex-
clusion of all first and last exons and single-exon genes.
5hmC count was plotted against the 20 bp flanking the 5’
and 3’ exon-intron boundaries on both the sense and anti-
sense strands.
Cluster analyses and gene ontology (GO)
Cluster analyses were performed using online software.
Briefly, a region was deemed to have a cluster of 5hmC
if there were at least three 5hmCs each within 200 bp of
each other. 5hmC clusters was located within a gene
body were assigned to that gene, otherwise 5hmC cluster
were assigned to the closest TSS from the center pos-
ition of the 5hmC cluster. GeneTrail [28] was used to
test for enrichment of functional annotations among
genes nearby 5hmC clusters (<250 kb), using the set of
all Ensembl genes as a background. Analysis was done
with default parameters and results corrected for
multiple testing by the method of Benjamini and Hoch-
berg to control the False Discovery Rate (FDR). GO
terms were deemed significant if they had an FDR-
corrected P ≤ 0.05. The background set included all
protein-coding genes.
Gender analyses
Cluster analyses for sites unique to females
5hmC sites in all 5 females were compared to 5hmC
sites detected in all 19 males. Cluster analyses, as de-
scribed above, were performed using only the 5hmC
sites unique to females.
Cluster analyses for sites unique to males
5 randomly selected sets of 5 males were used to deter-
mine male-specific 5hmC clusters. Briefly, all 5hmC sites
in each set, separately, were compared to 5hmC sites in
all 5 females. Cluster analyses, as described above, were
performed in each set using only the 5hmC sites unique
to the males in the respective set. Only the clusters that
were common in all of the 5 sets of males were deemed
to be male-specific.
X-inactivation
Genes involved in X-chromosome inactivation were taken
from previously published data [59]. Briefly, surveyed
genes were given a score from 0–9 based on the number
of individual hybrid lines detected from the inactivated X
chromosome. A score of 0 corresponds to complete
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inactivation, whereas a score of 9 corresponds to complete
escape from X-inactivation. Intragenic 5hmC patterns on
human X-linked genes were then compared between our
female and male subjects.
Availability of supporting data
The data sets supporting the results of this article will
be deposited in the GEO database.
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